Abeona Therapeutics (NASDAQ:ABEO) reported quarterly losses of $(2.08) per share. This is a 48 percent increase over losses of $(4.00) per share from the same period last year.
‘Not A Good Omen For Future,’ Says Cathie Wood As Economists Point To Worrisome Trends In Seemingly Strong Jobs Data
The Federal Reserve's stance against a rate cut is partly based on the perceived strength of the economy, supported by a robust labor market and resilient consumers.
